Protalix BioTherapeutics, Inc. ( PLX ) announced that it has enrolled the first patient in a 28 day open label, …read more
Protalix Drug in Phase IIa Study for Gaucher Disease – Analyst Blog
- by Bob Mitchell
Protalix BioTherapeutics, Inc. ( PLX ) announced that it has enrolled the first patient in a 28 day open label, …read more